Alors notez bien : les 28 février et 1er mars, c'est 48h Chrono Rencontrez les recruteurs à l'Iliade, parc expo de Chartres! 102 entreprises prêtes à vous rencontrer, des offres en CDD ...

Depuis 2005, l’année du centenaire du Rotary international, les Rotariens des 18 districts de France, réunis sous une même banière avec l’action Espoir en tête sont mobilisés pour la ...

Also, Novo Nordisk offers the possibility of viewing the Annual General Meeting via live webcast on Novo Nordisk's website. Please refer to the enclosed notice for the Annual General Meeting for ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug Wegovy and diabetes treatment Ozempic without a fight. An industry group ...

Danish drugmaker Novo Nordisk must like what it has seen in its two-year-old alliance with gene-silencing specialist Dicerna Pharma – it has just agreed to acquire the biotech for $3.3 billion ...

“These projects are key priorities for Novo and the team are eagerly awaiting the results from geological and geochemical sampling campaigns, expected in mid-March 2025, that will allow us to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Novo Nordisk (NYSE: NVO) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly) that's also probably bad news for Hims & Hers Health (NYSE: HIMS).

Les One du Barj - Louise au OFFLe 21/02/2025 Chartres Avec un regard piquant et une énergie débordante, elle se questionne sur l’amour sous toutes ses formes… et jusqu’où elle est prête à aller pour ...

After its potential kidney disease drug went down in flames late last year, Novo Nordisk is pinning the blame on alleged fraudulent claims by the drug’s original maker. The Danish pharma giant ...

Après le repli observé ces dernières semaines sur le titre Novo Nordisk A/S, le potentiel de baisse apparaît désormais limité par la proximité et la pertinence du support des 62.62 USD.